<p>Oscar Health（紐約證券交易所代碼：OSCR - 獲取免費報告）在週三發佈給客户和投資者的研究報告中，被巴克萊的股票分析師從 “持平” 評級上調至 “增持” 評級，MarketBeat.com 報道稱。該券商目前對該股票的目標價格為 35.00 美元。巴克萊的價格目標指向該股票從之前收盤價潛在上漲 28.90%。</p>
<ul>
<li>5 只具有爆炸性上漲潛力的小型股</li>
</ul>
<p>其他分析師也對該公司發佈了報告。Weiss Ratings 在 4 月 21 日的研究報告中重申了對 Oscar Health 股票的 “賣出（d）” 評級。Raymond James Financial 將 Oscar Health 的評級從 “市場表現” 上調至 “跑贏大盤”，並在 2 月 12 日的研究報告中設定了 18.00 美元的價格目標。瑞銀集團在 5 月 7 日的報告中將 Oscar Health 的價格目標從 15.00 美元上調至 20.00 美元，並給予該公司 “中性” 評級。Zacks Research 在 6 月 5 日的研究報告中將 Oscar Health 的評級從 “強力買入” 下調至 “持有”。最後，Wolfe Research 在 5 月 5 日的報告中開始覆蓋 Oscar Health，並對該股票給予 “同行表現” 評級。三位研究分析師對該股票給予了買入評級，八位分析師給予了持有評級，一位分析師給予了賣出評級。根據 MarketBeat 的數據，Oscar Health 的共識評級為 “持有”，平均價格目標為 20.78 美元。</p>
<p><strong>查看我們關於 OSCR 的最新報告</strong></p>
<h2>Oscar Health 股票下跌 0.9%</h2>
<p>Oscar Health 股票在週三開盤價為 27.15 美元。該公司的市值為 81.9 億美元，市盈率為-46.02，市盈增長比率為 1.92，貝塔值為 2.37。Oscar Health 的 12 個月低點為 10.69 美元，12 個月高點為 28.16 美元。該公司的 50 日移動平均線為 19.02 美元，200 日移動平均線為 16.25 美元。該公司的速動比率為 1.11，流動比率為 1.11，債務與股本比率為 0.26。</p>
<p>Oscar Health（紐約證券交易所代碼：OSCR - 獲取免費報告）在 5 月 6 日最後發佈了季度財報。該公司報告季度每股收益為 2.07 美元，超出分析師共識預期的 1.11 美元，超出幅度為 0.96 美元。Oscar Health 的淨利潤率為-0.30%，股本回報率為-3.26%。該公司在季度內的收入為 46.5 億美元，而分析師預期為 49 億美元。去年同期，該公司每股收益為 0.92 美元。該公司的季度收入同比增長 52.6%。作為一個整體，賣方分析師預測 Oscar Health 在當前財政年度將發佈 0.47 美元的每股收益。</p>
<h2>內部人士下注</h2>
<p>在相關消息中，首席執行官 Mark T. Bertolini 在 4 月 6 日的交易中購買了 1,000,000 股公司的股票。每股購買價格為 11.92 美元，總交易額為 11,920,000.00 美元。收購完成後，首席執行官直接持有公司 10,196,876 股股票，價值 121,546,761.92 美元。這筆交易代表了他們持股比例的 10.87% 的增加。該收購在與 SEC 的法律文件中披露，可以通過此鏈接訪問。此外，內部人士 Adam Mcananey 在 6 月 2 日的交易中出售了 9,859 股 Oscar Health 股票。每股出售價格為 21.94 美元，總價值為 216,306.46 美元。交易後，該內部人士直接持有 218,096 股公司股票，價值約為 4,785,026.24 美元。這筆交易是他們持股比例的 4.32% 的減少。該出售的披露在 SEC 文件中可用。該交易是在預先安排的 10b5-1 交易計劃下執行的。出售是為了覆蓋與股權獎勵歸屬相關的税收扣繳義務。在過去 90 天內，內部人士已出售價值 4,283,140 美元的 189,660 股公司股票。公司內部人士持有公司 25.11% 的股票。</p>
<h2>對 Oscar Health 的對沖基金看法</h2>
<p>一些對沖基金最近買入和賣出了該公司的股票。BIT Capital GmbH 在第四季度將其在 Oscar Health 的股份增加了 545.0%。BIT Capital GmbH 現在擁有 6,186,267 股公司股票，價值 88,897,000 美元，在上個季度又收購了 5,227,152 股。American Century Companies Inc.在第三季度將其在 Oscar Health 的持股增加了 89.0%。American Century Companies Inc.現在擁有 5,298,340 股公司股票，價值 100,298,000 美元，在上個季度又購買了 2,495,691 股。Farallon Capital Management LLC 在第三季度將其在 Oscar Health 的持股增加了 146.5%。Farallon Capital Management LLC 現在擁有 3,639,000 股公司股票，價值 68,886,000 美元，在上個季度又購買了 2,163,000 股。摩根士丹利在第四季度將其在 Oscar Health 的持股增加了 42.8%。摩根士丹利現在擁有 6,814,046 股公司股票，價值 97,918,000 美元，在上個季度又購買了 2,043,758 股。最後，美國銀行在第一季度將其在 Oscar Health 的持股增加了 205.1%。美國銀行現在擁有 2,860,310 股公司股票，價值 32,808,000 美元，在上個季度又購買了 1,922,732 股。75.70% 的股票由對沖基金和其他機構投資者持有。</p>
<h2>關於 Oscar Health</h2>
<p>（獲取免費報告）</p>
<p>Oscar Health，作為紐約證券交易所上市公司，股票代碼為 OSCR，是一家總部位於紐約的科技驅動健康保險公司。該公司由 Mario Schlosser、Joshua Kushner 和 Kevin Nazemi 於 2012 年創立，旨在簡化醫療保險覆蓋並提升會員體驗。Oscar 利用其專有的數字平台來簡化計劃註冊、索賠管理和會員支持，在個人、家庭和小型團體保險市場中脱穎而出。</p>
<p>公司的主要產品包括根據《平價醫療法案》提供的交易所內個人和家庭醫療計劃、交易所外計劃以及醫療保險優勢產品。</p>
<h2>瞭解更多</h2>
<ul>
<li>我們更看好的五隻股票比 Oscar Health 更好</li>
<li>光纖電纜公司：強勁的收益，但仍面臨障礙</li>
<li>父母銀行正在蓬勃發展——3 只值得關注的股票</li>
<li>康寧正在用玻璃鋪就人工智能的未來</li>
<li>為什麼亞馬遜突然落後於標準普爾 500 指數，這是否是一個警告？</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU9TQ1I?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU9TQ1I"/></p>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。如對本故事有任何問題或意見，請發送郵件至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1000 美元在 Oscar Health 嗎？</h2>
<p>在考慮 Oscar Health 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前……而 Oscar Health 並不在名單上。</p>
<p>雖然 Oscar Health 目前在分析師中獲得了持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

OSCR

OSCG

OSCX

<p>巴克萊將 Oscar Health（紐約證券交易所代碼：OSCR）的評級上調至 “增持”，目標價為 35 美元，理由是其潛在的上漲空間。其他分析師如雷蒙德·詹姆斯和瑞銀也調整了評級或目標價。首席執行官馬克·貝託利尼最近購買了 100 萬股，而內部人士亞當·麥克納尼則出售了一些股份。對沖基金 BIT Capital GmbH 和 American Century Companies 在最近幾個季度顯著增加了其持股</p>

<p>Oscar Health (NYSE:OSCR - Get Free Report) was upgraded by stock analysts at Barclays from an &#34;equal weight&#34; rating to an &#34;overweight&#34; rating in a research report issued to clients and investors on Wednesday, MarketBeat.com reports. The brokerage currently has a $35.00 target price on the stock. Barclays's price objective points to a potential upside of 28.90% from the stock's previous close.</p>
<div class="lb-trans"><p>Oscar Health（紐約證券交易所代碼：OSCR - 獲取免費報告）在週三發佈給客户和投資者的研究報告中，被巴克萊的股票分析師從 “持平” 評級上調至 “增持” 評級，MarketBeat.com 報道稱。該券商目前對該股票的目標價格為 35.00 美元。巴克萊的價格目標指向該股票從之前收盤價潛在上漲 28.90%。</p>
</div><ul>
<li>5 Small Cap Stocks With Explosive Upside Potential</li>
</ul>
<div class="lb-trans"><ul>
<li>5 只具有爆炸性上漲潛力的小型股</li>
</ul>
</div><p>Other analysts have also issued reports about the company. Weiss Ratings reaffirmed a &#34;sell (d)&#34; rating on shares of Oscar Health in a research report on Tuesday, April 21st. Raymond James Financial raised Oscar Health from a &#34;market perform&#34; rating to an &#34;outperform&#34; rating and set a $18.00 price objective for the company in a research note on Thursday, February 12th. UBS Group boosted their price objective on Oscar Health from $15.00 to $20.00 and gave the company a &#34;neutral&#34; rating in a report on Thursday, May 7th. Zacks Research lowered Oscar Health from a &#34;strong-buy&#34; rating to a &#34;hold&#34; rating in a research report on Friday, June 5th. Finally, Wolfe Research assumed coverage on Oscar Health in a report on Tuesday, May 5th. They issued a &#34;peer perform&#34; rating on the stock. Three research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, Oscar Health has a consensus rating of &#34;Hold&#34; and an average price target of $20.78.</p>
<div class="lb-trans"><p>其他分析師也對該公司發佈了報告。Weiss Ratings 在 4 月 21 日的研究報告中重申了對 Oscar Health 股票的 “賣出（d）” 評級。Raymond James Financial 將 Oscar Health 的評級從 “市場表現” 上調至 “跑贏大盤”，並在 2 月 12 日的研究報告中設定了 18.00 美元的價格目標。瑞銀集團在 5 月 7 日的報告中將 Oscar Health 的價格目標從 15.00 美元上調至 20.00 美元，並給予該公司 “中性” 評級。Zacks Research 在 6 月 5 日的研究報告中將 Oscar Health 的評級從 “強力買入” 下調至 “持有”。最後，Wolfe Research 在 5 月 5 日的報告中開始覆蓋 Oscar Health，並對該股票給予 “同行表現” 評級。三位研究分析師對該股票給予了買入評級，八位分析師給予了持有評級，一位分析師給予了賣出評級。根據 MarketBeat 的數據，Oscar Health 的共識評級為 “持有”，平均價格目標為 20.78 美元。</p>
</div><p><strong>View Our Latest Report on OSCR</strong></p>
<div class="lb-trans"><p><strong>查看我們關於 OSCR 的最新報告</strong></p>
</div><h2>Oscar Health Stock Down 0.9%</h2>
<div class="lb-trans"><h2>Oscar Health 股票下跌 0.9%</h2>
</div><p>Oscar Health stock opened at $27.15 on Wednesday. The company has a market capitalization of $8.19 billion, a PE ratio of -46.02, a PEG ratio of 1.92 and a beta of 2.37. Oscar Health has a 12-month low of $10.69 and a 12-month high of $28.16. The firm's fifty day moving average is $19.02 and its 200 day moving average is $16.25. The company has a quick ratio of 1.11, a current ratio of 1.11 and a debt-to-equity ratio of 0.26.</p>
<div class="lb-trans"><p>Oscar Health 股票在週三開盤價為 27.15 美元。該公司的市值為 81.9 億美元，市盈率為-46.02，市盈增長比率為 1.92，貝塔值為 2.37。Oscar Health 的 12 個月低點為 10.69 美元，12 個月高點為 28.16 美元。該公司的 50 日移動平均線為 19.02 美元，200 日移動平均線為 16.25 美元。該公司的速動比率為 1.11，流動比率為 1.11，債務與股本比率為 0.26。</p>
</div><p>Oscar Health (NYSE:OSCR - Get Free Report) last posted its quarterly earnings results on Wednesday, May 6th. The company reported $2.07 EPS for the quarter, topping analysts' consensus estimates of $1.11 by $0.96. Oscar Health had a negative net margin of 0.30% and a negative return on equity of 3.26%. The business had revenue of $4.65 billion during the quarter, compared to analysts' expectations of $4.90 billion. During the same period last year, the company posted $0.92 earnings per share. The business's quarterly revenue was up 52.6% on a year-over-year basis. As a group, sell-side analysts predict that Oscar Health will post 0.47 EPS for the current fiscal year.</p>
<div class="lb-trans"><p>Oscar Health（紐約證券交易所代碼：OSCR - 獲取免費報告）在 5 月 6 日最後發佈了季度財報。該公司報告季度每股收益為 2.07 美元，超出分析師共識預期的 1.11 美元，超出幅度為 0.96 美元。Oscar Health 的淨利潤率為-0.30%，股本回報率為-3.26%。該公司在季度內的收入為 46.5 億美元，而分析師預期為 49 億美元。去年同期，該公司每股收益為 0.92 美元。該公司的季度收入同比增長 52.6%。作為一個整體，賣方分析師預測 Oscar Health 在當前財政年度將發佈 0.47 美元的每股收益。</p>
</div><h2>Insiders Place Their Bets</h2>
<div class="lb-trans"><h2>內部人士下注</h2>
</div><p>In related news, CEO Mark T. Bertolini bought 1,000,000 shares of the company's stock in a transaction dated Monday, April 6th. The shares were bought at an average price of $11.92 per share, for a total transaction of $11,920,000.00. Following the completion of the acquisition, the chief executive officer directly owned 10,196,876 shares of the company's stock, valued at $121,546,761.92. This trade represents a 10.87% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Adam Mcananey sold 9,859 shares of Oscar Health stock in a transaction that occurred on Tuesday, June 2nd. The shares were sold at an average price of $21.94, for a total value of $216,306.46. Following the transaction, the insider directly owned 218,096 shares in the company, valued at approximately $4,785,026.24. The trade was a 4.32% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold 189,660 shares of company stock worth $4,283,140 in the last 90 days. Company insiders own 25.11% of the company's stock.</p>
<div class="lb-trans"><p>在相關消息中，首席執行官 Mark T. Bertolini 在 4 月 6 日的交易中購買了 1,000,000 股公司的股票。每股購買價格為 11.92 美元，總交易額為 11,920,000.00 美元。收購完成後，首席執行官直接持有公司 10,196,876 股股票，價值 121,546,761.92 美元。這筆交易代表了他們持股比例的 10.87% 的增加。該收購在與 SEC 的法律文件中披露，可以通過此鏈接訪問。此外，內部人士 Adam Mcananey 在 6 月 2 日的交易中出售了 9,859 股 Oscar Health 股票。每股出售價格為 21.94 美元，總價值為 216,306.46 美元。交易後，該內部人士直接持有 218,096 股公司股票，價值約為 4,785,026.24 美元。這筆交易是他們持股比例的 4.32% 的減少。該出售的披露在 SEC 文件中可用。該交易是在預先安排的 10b5-1 交易計劃下執行的。出售是為了覆蓋與股權獎勵歸屬相關的税收扣繳義務。在過去 90 天內，內部人士已出售價值 4,283,140 美元的 189,660 股公司股票。公司內部人士持有公司 25.11% 的股票。</p>
</div><h2>Hedge Funds Weigh In On Oscar Health</h2>
<div class="lb-trans"><h2>對 Oscar Health 的對沖基金看法</h2>
</div><p>A number of hedge funds have recently bought and sold shares of the company. BIT Capital GmbH grew its stake in shares of Oscar Health by 545.0% in the 4th quarter. BIT Capital GmbH now owns 6,186,267 shares of the company's stock worth $88,897,000 after acquiring an additional 5,227,152 shares in the last quarter. American Century Companies Inc. lifted its position in shares of Oscar Health by 89.0% during the third quarter. American Century Companies Inc. now owns 5,298,340 shares of the company's stock valued at $100,298,000 after purchasing an additional 2,495,691 shares in the last quarter. Farallon Capital Management LLC boosted its holdings in Oscar Health by 146.5% during the third quarter. Farallon Capital Management LLC now owns 3,639,000 shares of the company's stock worth $68,886,000 after purchasing an additional 2,163,000 shares during the last quarter. Morgan Stanley boosted its holdings in Oscar Health by 42.8% during the fourth quarter. Morgan Stanley now owns 6,814,046 shares of the company's stock worth $97,918,000 after purchasing an additional 2,043,758 shares during the last quarter. Finally, Bank of America Corp DE grew its position in Oscar Health by 205.1% in the 1st quarter. Bank of America Corp DE now owns 2,860,310 shares of the company's stock worth $32,808,000 after purchasing an additional 1,922,732 shares in the last quarter. 75.70% of the stock is owned by hedge funds and other institutional investors.</p>
<div class="lb-trans"><p>一些對沖基金最近買入和賣出了該公司的股票。BIT Capital GmbH 在第四季度將其在 Oscar Health 的股份增加了 545.0%。BIT Capital GmbH 現在擁有 6,186,267 股公司股票，價值 88,897,000 美元，在上個季度又收購了 5,227,152 股。American Century Companies Inc.在第三季度將其在 Oscar Health 的持股增加了 89.0%。American Century Companies Inc.現在擁有 5,298,340 股公司股票，價值 100,298,000 美元，在上個季度又購買了 2,495,691 股。Farallon Capital Management LLC 在第三季度將其在 Oscar Health 的持股增加了 146.5%。Farallon Capital Management LLC 現在擁有 3,639,000 股公司股票，價值 68,886,000 美元，在上個季度又購買了 2,163,000 股。摩根士丹利在第四季度將其在 Oscar Health 的持股增加了 42.8%。摩根士丹利現在擁有 6,814,046 股公司股票，價值 97,918,000 美元，在上個季度又購買了 2,043,758 股。最後，美國銀行在第一季度將其在 Oscar Health 的持股增加了 205.1%。美國銀行現在擁有 2,860,310 股公司股票，價值 32,808,000 美元，在上個季度又購買了 1,922,732 股。75.70% 的股票由對沖基金和其他機構投資者持有。</p>
</div><h2>About Oscar Health</h2>
<div class="lb-trans"><h2>關於 Oscar Health</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.</p>
<div class="lb-trans"><p>Oscar Health，作為紐約證券交易所上市公司，股票代碼為 OSCR，是一家總部位於紐約的科技驅動健康保險公司。該公司由 Mario Schlosser、Joshua Kushner 和 Kevin Nazemi 於 2012 年創立，旨在簡化醫療保險覆蓋並提升會員體驗。Oscar 利用其專有的數字平台來簡化計劃註冊、索賠管理和會員支持，在個人、家庭和小型團體保險市場中脱穎而出。</p>
</div><p>The company's primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.</p>
<div class="lb-trans"><p>公司的主要產品包括根據《平價醫療法案》提供的交易所內個人和家庭醫療計劃、交易所外計劃以及醫療保險優勢產品。</p>
</div><h2>Read More</h2>
<div class="lb-trans"><h2>瞭解更多</h2>
</div><ul>
<li>Five stocks we like better than Oscar Health</li>
<li>Optical Cable Corporation: Strong Earnings, But Hurdles Remain</li>
<li>The Bank of Mom and Dad Is Booming—3 Stocks to Watch</li>
<li>Corning Is Paving AI's Future With Glass</li>
<li>Why's Amazon Suddenly Lagging the S&amp;P 500, and Is It a Warning?</li>
</ul>
<div class="lb-trans"><ul>
<li>我們更看好的五隻股票比 Oscar Health 更好</li>
<li>光纖電纜公司：強勁的收益，但仍面臨障礙</li>
<li>父母銀行正在蓬勃發展——3 只值得關注的股票</li>
<li>康寧正在用玻璃鋪就人工智能的未來</li>
<li>為什麼亞馬遜突然落後於標準普爾 500 指數，這是否是一個警告？</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU9TQ1I" alt="" original-src="https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx?Prefix=NYSE&amp;Symbol=OSCR"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。如對本故事有任何問題或意見，請發送郵件至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Oscar Health Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1000 美元在 Oscar Health 嗎？</h2>
</div><p>Before you consider Oscar Health, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 Oscar Health 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前……而 Oscar Health 並不在名單上。</p>
</div><p>While Oscar Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Oscar Health 目前在分析師中獲得了持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Oscar Health（NYSE:OSCR）在巴克萊被上調至 “增持” 評級